Abstract:BackgroundParkinson's disease (PD) is characterized by dopaminergic neuronal loss in the substantia nigra pars compacta and intracellular inclusions called Lewy bodies (LB). During the course of disease, misfolded α-synuclein, the major constituent of LB, spreads to different regions of the brain in a prion-like fashion, giving rise to successive non-motor and motor symptoms. Etiology is likely multifactorial, and involves interplay among aging, genetic susceptibility and environmental factors.Main bodyThe prevalence of PD rises exponentially with age, and aging is associated with impairment of cellular pathways which increases susceptibility of dopaminergic neurons to cell death. However, the majority of those over the age of 80 do not have PD, thus other factors in addition to aging are needed to cause disease. Discovery of neurotoxins which can result in parkinsonism led to efforts in identifying environmental factors which may influence PD risk. Nevertheless, the causality of most environmental factors is not conclusively established, and alternative explanations such as reverse causality and recall bias cannot be excluded. The lack of geographic clusters and conjugal cases also go against environmental toxins as a major cause of PD. Rare mutations as well as common variants in genes such as SNCA, LRRK2 and GBA are associated with risk of PD, but Mendelian causes collectively only account for 5% of PD and common polymorphisms are associated with small increase in PD risk. Heritability of PD has been estimated to be around 30%. Thus, aging, genetics and environmental factors each alone is rarely sufficient to cause PD for most patients.ConclusionPD is a multifactorial disorder involving interplay of aging, genetics and environmental factors. This has implications on the development of appropriate animal models of PD which take all these factors into account. Common converging pathways likely include mitochondrial dysfunction, impaired autophagy, oxidative stress and neuroinflammation, which are associated with the accumulation and spread of misfolded α-synuclein and neurodegeneration. Understanding the mechanisms involved in the initiation and progression of PD may lead to potential therapeutic targets to prevent PD or modify its course.

Exploring potential developmental origins of common neurodegenerative disorders

Analyses of the Similarity and Difference of Global Gene Expression Profiles in Cortex Regions of Three Neurodegenerative Diseases: Sporadic Creutzfeldt-Jakob Disease (scjd), Fatal Familial Insomnia (FFI), and Alzheimer’s Disease (AD)

Contributing Factors of Neurodegeneration in Alzheimer’s Disease

Identifying the earliest-occurring clinically targetable precursors of late-onset Alzheimer's disease

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines

New Insights Into the Pathogenesis of Alzheimer's Disease

Cellular senescence and neurodegeneration

Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?

Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease

Gut-Brain Nexus: Mapping Multi-Modal Links to Neurodegeneration at Biobank Scale

Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases

Exploring the “Multiple-Hit Hypothesis” of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat

Biomarkers for Managing Neurodegenerative Diseases

Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration

Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View

A review of proposed mechanisms for neurodegenerative disease

Etiological Insights and Degradation Strategies

Multi-ancestry population attributable risk assessment of common genetic variation in Alzheimer's and Parkinson's diseases

Genetics impact risk of Alzheimer’s disease through mechanisms modulating structural brain morphology in late life